Latest Excimer Technology That Treats Quickly & Painlessly Vitiligo Psoriasis Alopecia Areata Atopic Dermatitis Mycosis Fungoidis
ABOUT US
Your Expertise, Our Device
Covering Every Step of Treating Skin Conditions
Clarteis is a France-based medical technology company specializing in dermatological phototherapy solutions. Its flagship system, Exciplex®, uses targeted 308 nm excimer light to treat conditions such as vitiligo, psoriasis, and alopecia areata. By delivering precise ultraviolet energy to affected skin areas, Clarteis enables effective, localized treatment while minimizing exposure to healthy tissue, supporting safer and more efficient clinical outcomes in modern dermatology.
We are all about helping dermatologists to treat skin conditions with the latest excimer light technology, letting patients get a treatment with minimal side effects.
Our Impact in Numbers
Exceiplex
Exciplex is the latest excimer technology developed after years of reasrch by well-known physicist in France. It is trusted world-wide, and is approved by CE & FDA. Your patients will love it!
Coming Soon
Can you just guess what product we are working on right now? This technology will change the way dermatologists adopt strategies to make your body more attractive. Stay stuned!
Our Products
Concept & Technology Design
This phase defines the 308 nm exciplex system architecture, including light source selection, delivery design, and therapeutic targets. Prototypes are developed and tested to ensure wavelength accuracy, stability, usability, and clinical relevance.
Preclinical & Safety Validation
The device undergoes laboratory testing on skin models to assess biological effects, determine safe dosage ranges, and identify risks. Parameters are refined to ensure consistent performance, safety, and effectiveness before progressing further.
Clinical Development & Regulatory Approval
Clinical studies in patients confirm safety and efficacy. Data supports regulatory approval, such as CE marking. After approval, manufacturing is scaled, protocols are standardized, and the device is introduced into dermatological clinical practice.
Laurent Meilhac
Founder & CEO
Meet Our CEO
Laurent Meilhac is a physicist, entrepreneur, and innovator in dermatology technology. He founded Clarteis with the mission of developing advanced light-based medical devices to improve the lives of patients suffering from autoimmune skin conditions such as vitiligo and psoriasis.
✔ PhD in Laser Physics
✔ Founder of Dermoptics & Clarteis
✔ Dermatology Innovator
"My mission is to provide dermatologists worldwide with innovative tools that improve the lives of patients."